Allurion, a Natick company making a gastric weight-loss balloon that doesn’t require an operation, has more than doubled its capacity and workforce this year, with high hopes accompanying planned U.S. regulatory approval in 2020.
The company that makes and sells OxyContin has reportedly agreed to a settlement with 22 state attorneys general and thousands of municipalities, but not Massachusetts Attorney General Maura Healey, who is pledging to continue her fight against Purdue Pharma.
The secretary of the U.S. Department of Health and Human Services said Wednesday the federal government is putting policies in place to ban the sale of flavored e-cigarettes.
New audit results suggest state regulators have not properly prioritized and conduct investigations of cases of alleged mistreatment of nursing home residents in Massachusetts, prompting a call for change from from Auditor Suzanne Bump.
Talks between state attorneys general and Purdue Pharma over a possible $12 billion settlement to resolve thousands of lawsuits brought against the opioid manufacturer have stalled, in part because Massachusetts Attorney General Maura Healey is not on board, according to Reuters.
A UMass Medical School and UMass Memorial Medical Center initiative for supporting drug overdose and prevention research is holding a symposium with dozens of area agencies Thursday.
Doctors at UMass Memorial Medical Center in Worcester are the first in New England to use a newly approved device that has been used in only 3,000 procedures to treat aneurysms.
Massachusetts Attorney General Maura Healey, who sued OxyContin manufacturer Purdue Pharma, wouldn't comment Wednesday on reports of a possible $12 billion settlement that would resolve thousands of lawsuits targeting the company for its role in the opioid epidemic.